U
RMD icon

UBS’s ResMed RMD Stock Holding History

UBS’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$233K Buy
4,720
+4,620
+4,620% +$235K ﹤0.01% 5036
2014
Q2 		$5K Sell
100
-100
-50% -$4.96K ﹤0.01% 9526
2014
Q1 		$9K Sell
200
-100
-33% -$4.49K ﹤0.01% 9024
2013
Q4 		$14K Sell
300
-1,200
-80% -$60.7K ﹤0.01% 8603
2013
Q3 		$79K Buy
1,500
+200
+15% +$9.7K ﹤0.01% 6297
2013
Q2 		$59K Buy
+1,300
New +$61.7K ﹤0.01% 6534

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS's RMD Position: Q3 2014 in Review

UBS reduced its ResMed (RMD) stake by 2.5% in Q3 2014, selling an estimated $74.9K and leaving 58,548 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

UBS first reported a position in RMD in Q2 2013 and has held it in 6 quarters since. The position peaked at $11M in Q1 2014. 300 funds tracked by Wall St. Rank hold RMD as of Q3 2014.

  • UBS held 58,548 shares of ResMed worth $2.88M as of Q3 2014.
  • UBS sold 1,471 ResMed shares in Q3 2014, an estimated $74.9K.
  • ResMed made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2568 holding.
  • UBS first reported a position in ResMed in Q2 2013 and has held it in 6 quarters since.
  • UBS's ResMed position peaked at $11M in Q1 2014.
  • 300 funds tracked by Wall St. Rank held ResMed as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.